8-KOther EventsExhibits & Filings

Cencora, Inc. 8-K Report, Corporate Update (Aug 7, 2006)

Filed August 7, 2006For Securities:COR

Summary

AmerisourceBergen Corporation (now Cencora, Inc.) announced on August 7, 2006, a significant strategic move to combine its institutional pharmacy business, PharMerica Long-Term Care (PharMerica LTC), with Kindred Healthcare, Inc.'s institutional pharmacy business, Kindred Pharmacy Services (KPS). This proposed transaction, outlined in a non-binding letter of intent, aims to create a new, independent, publicly traded company. Upon completion, this new entity is intended to be jointly owned, with AmerisourceBergen and Kindred stockholders each holding a 50% stake. This development signals a potential shift in the landscape of institutional pharmacy services, allowing AmerisourceBergen to potentially focus on its core drug distribution business while participating in the upside of a newly formed, dedicated institutional pharmacy operation. Investors should monitor the progress of this non-binding agreement as it moves towards a definitive transaction.

Key Highlights

  • 1AmerisourceBergen Corporation and Kindred Healthcare, Inc. have signed a non-binding letter of intent to combine their institutional pharmacy businesses.
  • 2The businesses to be combined are AmerisourceBergen's PharMerica Long-Term Care (PharMerica LTC) and Kindred's Kindred Pharmacy Services (KPS).
  • 3The combination will result in the creation of a new, independent, publicly traded company.
  • 4Both AmerisourceBergen and Kindred stockholders are expected to own 50% of the new entity upon completion of the transaction.
  • 5This is a strategic move for AmerisourceBergen, potentially allowing greater focus on its core drug distribution operations.
  • 6The agreement is currently non-binding, indicating further negotiation and due diligence are required.

Frequently Asked Questions

The main purpose of this filing is to announce a non-binding letter of intent between AmerisourceBergen and Kindred Healthcare to combine their respective institutional pharmacy businesses into a new, independent, publicly traded company.

The specific segments involved are AmerisourceBergen's PharMerica Long-Term Care (PharMerica LTC) and Kindred Healthcare's Kindred Pharmacy Services (KPS).

The new company is intended to be jointly owned, with AmerisourceBergen stockholders and Kindred stockholders each holding a 50% stake upon completion of the transaction.

No, the letter of intent is non-binding. This means further negotiations, definitive agreements, and regulatory approvals will be necessary before the transaction can be completed. Investors should await further announcements regarding definitive terms.